קומפיוג'ן תקבל תשלום בגין אבן דרך נוספת בעקבות מתן טיפול ב Rilvegostomig לנבדק ראשון בניסוי קליני שני הנמצא בשלב 3
false
קומפיוגן בע"מ
2
380
COMPUGEN LTD
Corporation no:
511779639
12833
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
30/05/2024
www.isa.gov.il
www.tase.co.il
Reference:
2024-02-054691
Time of broadcast:
11:19
11:19
The corporation scheduled the publication of the report to
30/05/2024 14:00
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
קומפיוג'ן תקבל תשלום בגין אבן דרך נוספת בעקבות מתן טיפול ב Rilvegostomig לנבדק ראשון בניסוי קליני שני הנמצא בשלב 3
a2431543_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
TASE
Date of revision of form structure:
07/05/2024
Address:
Harokmim
26
,
Holon
5885849
,
Israel
Tel:
03-7658585
,
03-7658525
Fax:
03-7658555
E-mail address:
donnag@cgen.com
Previous names of reporting entity:
Name of the Signatory:
Ben Dor Eran
Position of Signatory in the reporting corporation:
General Counsel & Corporate Secretary
Name of Employer Company:
Address:
Harokmim
26
,
Holon
5885849
Telephone:
03-7658585
Facsimile:
03-7658555
E-mail:
eranbd@cgen.com
2
Israel